Heartseed Inc. is pleased to announce that Dr. Takehiko Kaneko, Chief Medical Officer and Board Director, will speak at the International Society for Cell & Gene Therapy (ISCT) 2025 Annual Meeting, to be held in May 2025 in New Orleans, USA.

ISCT 2025 website

The ISCT Annual Meeting is one of the world's largest conferences in the field of cell and gene therapy. The event brings together stakeholders from academia, industry, and regulatory authorities worldwide to discuss the latest scientific advances, development challenges, and regulatory trends.

Dr. Kaneko will participate in the ISCT iPSC Signature Series, Session III: Building Frameworks Using iPSC Products, scheduled for Saturday, May 10. He will present practical examples from Heartseed's manufacturing and quality control processes for iPSC-derived cardiomyocyte spheroids, and join discussions on building safety characterization frameworks tailored to product attributes and development stages.

The iPSC Signature Series is a specialized session focused on the safety evaluation of iPSC-derived therapies as they move toward clinical application. It features the latest insights on standardization and regulatory requirements. Dr. Kaneko will share Heartseed's established manufacturing and quality strategies, and how these approaches have contributed to ensuring safety in ongoing clinical trials.